Attached files
| file | filename |
|---|---|
| 10-Q - PANA-MINERALES S.A. 10-Q NOVEMBER 30, 2009 - Cortronix Biomedical Advancement Technologies Inc. | body_panaminerales10knov09.htm |
| EX-99.1 - CERTIFICATE RULE 13A-14A HECTOR DAVIS, CEO, CFO - Cortronix Biomedical Advancement Technologies Inc. | cert13a14ahectordavisceocfo.htm |
Exhibit
99.2
CERTIFICATE
PURSUANT TO
18 U.S.C.
SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report (the “Report”) on the Form 10-Q of
Pana-Minerales S.A. (the “Company”) for the three months ended November 30,
2009, as filed with the Securities and Exchange Commission on the date hereof,
I, Hector Francisco Vazquez Davis, Chief Executive Officer, Chief Financial
Officer, President, Secretary Treasurer and Director, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:
1. The
Quarterly Report fully complies with the requirements of Section 13 (a) or 15
(d) of the Securities and Exchange Act of 1934, as amended; and
2. The
information contained in this Quarterly Report fairly presents, in all material
respects, the financial condition and results of operation of the
Company.
Date:
January 11, 2010
HECTOR FRANCISCO VASQUEZ
DAVIS
Hector
Francisco Vasquez Davis
Chief
Executive Officer, Chief Financial Officer
President,
Secretary Treasurer and Director
-1-